eXoZymes
Develops AI-assisted enzymes for making small molecules in cell-free bioreactors.
$7.25
After-hours close−0.09 (−1.23%)
At close$7.34(+2.30%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 0.68%62.9K sharesInsiders 16.53%1.53M sharesOther 82.79%7.68M shares
Shares outstanding 9.28M · Float 2.48M · 26.7% free float
Institutions13F, as of Mar 31, 2026
7 holders · 62.9K shares · 2 new positions · 5 increased · 1 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 22.2K | 0.24% | +22.2Knew | May 15, 2026 |
| Geode Capital Management, LLC | 21.9K | 0.24% | −1.7K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 9.4K | 0.10% | +9.4Knew | May 8, 2026 |
| BlackRock, Inc. | 6.8K | 0.07% | +546 | May 13, 2026 |
| Tower Research Capital LLC (TRC) | 1.3K | 0.01% | +1.3K | May 15, 2026 |
| Morgan Stanley | 1.3K | 0.01% | 0 | May 15, 2026 |
| UBS Group AG | 24 | 0.00% | +21 | May 5, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Christopher A. Marlettincl. MDB Capital Holdings, LLC, Anthony DiGiandomenico | 43.61% | 4.16M | 13D | Nov 18, 2024 ↗ |
| Tyler Korman | 8.74% | 832.6K | 13D | Nov 18, 2024 ↗ |
| Paul Opgenorth | 7.81% | 744.3K | 13D | Nov 18, 2024 ↗ |
| James U Bowie | 6.27% | 597.4K | 13D | Nov 18, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Tyler Paz Korman | officer: Chief Scientific Officer | 762.8K | 8.22% | Aug 25, 2026 |
| Paul Hideo Opgenorth | officer: Vice President, Development | 645.1K | 6.95% | Apr 8, 2026 |
| Edgardo Javier Rayo | director | 77.9K | 0.84% | Mar 25, 2025 |
| Damien Alan Perriman | officer: Chief Commercial Officer | 28.5K | 0.31% | Aug 25, 2026 |
| Michael Heltzen | officer: Chief Executive Officer | 10.6K | 0.11% | Jul 2, 2025 |
| Fouad Nawaz | officer: Vice President- Finance | 9.5K | 0.10% | Apr 8, 2026 |
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 9, 2026 | Tyler Paz Kormanofficer: Chief Scientific Officer | Sale | 750 | $10.53 | 729,123 |
| Apr 8, 2026 | Tyler Paz Kormanofficer: Chief Scientific Officer | Sale | 750 | $10.04 | 729,873 |
CongressHouse and Senate disclosures
Not reported.